Our Team

Each Partner brings extensive industry knowledge, unrivaled relationships and substantial deal experience, resulting in a team of the industry's most sought after advisors

Mark J. Robinson


With over 25 years of investment banking experience, Mark Robinson has advised many of the most prominent pharmaceutical, biotechnology and medical device companies in the healthcare industry.

Selected assignments while at Centerview include being the adviser to Pharmacyclics on its $21 billion sale to AbbVie, Array on its $11.8 billion sale to Pfizer, Onyx in its $10.4 billion sale to Amgen, Intermune on its $8.9 billion sale to Roche, Avexis on its $8.7 billion sale to Novartis, Receptos on its $7.8 billion sale to Celgene, Auris Health on its sale for up to $5.8 billion to Johnson & Johnson, Tesaro on its $5.1 billion sale to GlaxoSmithKline, Spark on its $4.8 billion sale to Roche, Questcor on its $5.6 billion merger with Mallinckrodt, OSI on its hostile defense and $4 billion sale to Astellas, Idenix in its $3.8 billion sale to Merck, Avanir in its $3.5 billion sale to Otsuka, Biogen on its defense against Icahn and acquisition of control of Tysabri from Elan, Audentes on its $3.0 billion sale to Astellas, Alder BioPharmaceuticals on its $2.0 billion sale to Lundbeck, Tobira on its sale for up to $1.7 billion to Allergan, and Relypsa in its $1.5 billion sale to Galenica.

Prior to Centerview, Mr. Robinson spent 12 years at Merrill Lynch in San Francisco where he had been Global Co-Head of Healthcare Investment Banking for the last six of those years.  Notable historic landmark transactions include advising Immunex in its $16 billion sale to Amgen and IDEC in its $7 billion merger with Biogen to create Biogen Idec, Vertex in its acquisition of Aurora and Illumina in its purchase of Solexa. Mr. Robinson joined Merrill Lynch in 1998 to build the biotechnology and medical devices investment banking efforts after working at CS First Boston and Robertson Stephens.

Mr. Robinson currently is Chairman of the Board of the College of Letters and Science at U.C. Berkeley and on the Board of Trustees of the U.C. Berkeley Foundation and The Thacher School. He is also a member of the Council on Foreign Relations.


Mr. Robinson received his B.A. from the University of California Berkeley and an M.B.A. from Harvard Business School.

Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

Centerview is honored to partner with leading charitable organizations in active support of our charities:

  • Arts Connection
  • NY Cares
  • Bottomless Closet
Kohlberg & Company, LLC
Announced: Q3 2020
Status: Pending

Exclusive financial advisor to the Kohlberg consortium on its majority stake in PCI Pharma Services
View All
New York

Centerview Partners LLC

31 West 52nd Street

22nd Floor

New York, New York 10019

(212) 380-2650 | Tel
(212) 380-2651 | Fax

Centerview Partners UK LLP

100 Pall Mall

3rd Floor

London SW1Y 5NQ

02074099700 | Tel
02074099704 | Fax

Centerview Partners France SCS

16 Avenue Matignon

4th Floor

Paris 75008

0180200620 | Tel
0180200621 | Fax
Palo Alto

Centerview Partners LLC

600 Ramona St.

Suite 300

Palo Alto, California 94301

(650) 822-5800 | Tel
(650) 822-5801 | Fax
San Francisco

Centerview Partners LLC

555 California Street

Suite 4300

San Francisco, California 94104

(415) 400-0900 | Tel
(415) 400-0901 | Fax


Centerview Partners LLC

Los Angeles

Centerview Partners LLC

Copyright © 2008 - 2020 Centerview Partners Holdings LP. All Rights Reserved. | Privacy and Other Notices

Centerview Partners LLC, member SIPC